Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.2K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

1.2K
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.2K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

1000
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1000
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

618
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
618
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

551
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
551
Hypoxia01:23

Hypoxia

2.3K
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The ARDS, Pneumonia, and Sepsis (APS) Consortium: Rationale, Design, and Feasibility of a National Platform for Phenotyping Critical Illness Syndromes.

Chest·2026
Same author

Alpha2 agonists for sedation to produce better outcomes for adults with critical illness: a synopsis of the A2B RCT with cost-effectiveness and process evaluation.

Health technology assessment (Winchester, England)·2026
Same author

The Association Between Sepsis Coding and Payment to U.S. Hospitals.

Health services research·2026
Same author

Mucoactive agents in bronchiectasis: a systematic review and meta-analysis.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

Comorbidities, Weight-Based Initial Fluid Resuscitation, and Mortality in Patients With Sepsis.

JAMA network open·2026
Same author

Association of White Blood Cell Count with Treatment Response to Cefepime vs Piperacillin-Tazobactam.

American journal of respiratory and critical care medicine·2026

Related Experiment Video

Updated: Feb 25, 2026

Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock
07:48

Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock

Published on: October 28, 2022

1.6K

Late mortality after acute hypoxic respiratory failure.

Hallie C Prescott1,2,3, Michael W Sjoding1,2, Kenneth M Langa1,2,3,4

  • 1Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA.

Thorax
|August 7, 2017
PubMed
Summary

Acute hypoxic respiratory failure (AHRF) increases late mortality risk, but most of this risk stems from the initial hospitalization event, not AHRF itself. This finding is crucial for understanding long-term outcomes in elderly patients.

Keywords:
ArdsAssisted VentilationClinical EpidemiologyRespiratory Infection

More Related Videos

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

3.9K
A Swine Model of Neonatal Asphyxia
10:36

A Swine Model of Neonatal Asphyxia

Published on: October 11, 2011

14.9K

Related Experiment Videos

Last Updated: Feb 25, 2026

Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock
07:48

Noninvasive and Invasive Renal Hypoxia Monitoring in a Porcine Model of Hemorrhagic Shock

Published on: October 28, 2022

1.6K
Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS
06:22

Surfactant Depletion Combined with Injurious Ventilation Results in a Reproducible Model of the Acute Respiratory Distress Syndrome ARDS

Published on: April 7, 2021

3.9K
A Swine Model of Neonatal Asphyxia
10:36

A Swine Model of Neonatal Asphyxia

Published on: October 11, 2011

14.9K

Area of Science:

  • Pulmonary and Critical Care Medicine
  • Geriatric Medicine
  • Health Services Research

Background:

  • Acute hypoxic respiratory failure (AHRF) is a critical condition with significant acute mortality.
  • The primary drivers of late mortality (beyond 30 days) in AHRF survivors remain unclear, with contributions from pre-existing conditions, the inciting event, or AHRF itself being debated.

Purpose of the Study:

  • To investigate the independent contribution of AHRF to late mortality in elderly patients.
  • To differentiate the impact of AHRF from the effects of the acute events that precipitate it on long-term survival.

Main Methods:

  • An observational cohort study utilized US Health and Retirement Study (HRS) data from fee-for-service Medicare (1998-2012).
  • Patients hospitalized with AHRF were matched to non-hospitalized controls and to patients hospitalized for acute events (at-risk hospitalizations).
  • Late mortality was assessed from 31 days to 2 years post-hospitalization.

Main Results:

  • AHRF hospitalization was associated with a 24.4% absolute increase in late mortality compared to non-hospitalized individuals.
  • Compared to at-risk hospitalizations, AHRF conferred a smaller, yet significant, 6.7% increase in late mortality.
  • Hospitalization for acute inciting events explained 71.2% of the increased late mortality risk, while AHRF itself accounted for 28.8%.

Conclusions:

  • In older Americans, approximately 25% of late deaths in AHRF survivors are not attributable to pre-existing health status.
  • The majority of increased late mortality risk (over 70%) is linked to the acute events precipitating AHRF, rather than AHRF development.
  • While AHRF contributes to late mortality, the underlying cause of hospitalization plays a more substantial role in long-term outcomes.